Virtu Financial LLC Savara Inc Transaction History

Virtu Financial LLC

$1.82 Billion
Q3 2024

A detailed history of Virtu Financial LLC transactions in Savara Inc stock. As of the latest transaction made, Virtu Financial LLC holds 15,853 shares of SVRA stock, worth $50,729. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,853

Holding current value

$50,729

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 20, 2024	BUY	$3.96 - $5.07 $62,777 - $80,374	15,853 New	15,853 $67,000
Q3 2021 Nov 12, 2021	SELL	$1.18 - $1.64 $19,716 - $27,402	-16,709 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$1.51 - $2.29 $25,230 - $38,263	16,709 New	16,709 $28,000
Q3 2020 Dec 11, 2020	SELL	$1.09 - $2.21 $23,262 - $47,165	-21,342 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$1.8 - $3.05 $5,455 - $9,244	-3,031 Reduced 12.44%	21,342 $53,000
Q4 2019 Feb 04, 2020	BUY	$0.71 - $4.91 $17,304 - $119,671	24,373 New	24,373 $109,000
Q3 2019 Nov 20, 2019	SELL	$2.16 - $3.2 $159,161 - $235,795	-73,686 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$2.37 - $11.7 $174,635 - $862,126	73,686 New	73,686 $175,000
Q1 2019 Apr 12, 2019	SELL	$6.71 - $8.6 $72,474 - $92,888	-10,801 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$6.27 - $10.92 $11,718 - $20,409	-1,869 Reduced 14.75%	10,801 $82,000
Q1 2018 May 14, 2018	SELL	$8.99 - $14.95 $167,375 - $278,339	-18,618 Reduced 59.51%	12,670 $117,000
Q4 2017 Feb 09, 2018	BUY	$8.26 - $16.76 $258,438 - $524,386	31,288	31,288 $464,000

Others Institutions Holding SVRA

# of Institutions

128

Shares Held

158M

Call Options Held

67.6K

Put Options Held

29.4K

Nea Management Company, LLC Timonium, MD

24.5M
Shares

$78.3 Million
7.93% of portfolio
Bain Capital Life Sciences Investors, LLC Boston, MA

14.6M
Shares

$46.6 Million
11.08% of portfolio
Tcg Crossover Management, LLC Palo Alto, CA

12.4M
Shares

$39.6 Million
6.8% of portfolio
Wellington Management Group LLP Boston, MA

8.62M
Shares

$27.6 Million
0.01% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

8.16M
Shares

$26.1 Million
1.86% of portfolio

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $365M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Account